Sri Lanka
Diabetes country report 2000 — 2050
Skip Map
Number of adults (20–79 years) with diabetes in Sri Lanka (LK)
| 2000 | 335.4 thousand |
| 2011 | 1.1 million |
| 2024 | 1.6 million |
| 2050 | 1.9 million |
Sri Lanka is one of the seven countries and territories in the IDF South-East Asia Region. Sri Lanka has the third highest number of adults (20-79 years) with diabetes in the Region.
Data source(s) used for the diabetes estimates in adults:
- Katulanda P, Constantine GR, Mahesh JG, et al Diabet Med. 2008 Sep;25(9):1062-9. PMID:19183311.
- Wijewardene K, Mohideen MR, Mendis S, et al Ceylon Med J. 2005 Jun;50(2):62-70. PMID:16114771.
- Ravindra Prasan Rannan-Eliya, Nilmini Wijemunige, Prasadini Perera et al. BMJ Open Diabetes Res Care. 2023 Feb;11(1):e003160. doi: 10.1136/bmjdrc-2022-003160. PMID:36796852
2000
2011
2024
2050
Loading...
| Diabetes estimates (20-79 y) | ||||
|---|---|---|---|---|
| People with diabetes, in 1,000s | 335.4 | 1,079.8 | 1,600.5 | 1,911.7 |
| Age-standardised prevalence of diabetes, % | - | 7.5 | 10.2 | 11.9 |
| Proportion of people with undiagnosed diabetes, % | - | - | 37.7 | - |
| People with undiagnosed diabetes, in 1,000s | - | - | 603.4 | - |
| Impaired Fasting Glucose (IFG) | ||||
|---|---|---|---|---|
| People with IFG, in 1,000s | - | - | 1,528.2 | 1,632.9 |
| Age-standardised prevalence of IFG, % | - | - | 10.1 | 10.5 |
| Impaired Glucose Tolerance (IGT) | ||||
|---|---|---|---|---|
| People with IGT, in 1,000s | - | 767.3 | 2,889.6 | 3,302.1 |
| Age-standardised prevalence of IGT, % | - | 5.4 | 19.2 | 21.4 |
| Mortality attributable to diabetes (20-79 y) | ||||
|---|---|---|---|---|
| Deaths attributable to diabetes | - | 15,203.0 | 4,159.9 | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 3.9 | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
|---|---|---|---|---|
| Live births affected by HIP | - | - | 42,390.2 | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | 11.2 | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | 4,030.7 | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | 6,660.8 | - |
| Diabetes-related health expenditure | ||||
|---|---|---|---|---|
| Total diabetes-related health expenditure, USD million | - | - | 298.5 | 353.3 |
| Total diabetes-related health expenditure, ID million | - | - | 979.7 | 1,159.7 |
| Diabetes-related health expenditure per person, USD | - | 117.0 | 186.5 | 184.8 |
| Diabetes-related health expenditure per person, ID | - | - | 612.2 | 606.7 |
| Type 1 diabetes estimates in children and adolescents | ||||
|---|---|---|---|---|
| People with type 1 diabetes (all age groups) | - | - | 15,348.0 | - |
| People with type 1 diabetes (0-19 y) | - | - | 4,412.1 | - |
| Demographics | ||||
|---|---|---|---|---|
| Total adult population (20-79 y), in 1,000s | 11,757.0 | 13,893.8 | 14,897.1 | 15,309.0 |
| Population of children and adolescents (0-19 y) | - | - | 6,898,458.5 | - |
Loading...
| Diabetes estimates (20-79 y) | |
|---|---|
| People with diabetes, in 1,000s | 335.4 |
| Age-standardised prevalence of diabetes, % | - |
| Proportion of people with undiagnosed diabetes, % | - |
| People with undiagnosed diabetes, in 1,000s | - |
| Impaired Fasting Glucose (IFG) | |
|---|---|
| People with IFG, in 1,000s | - |
| Age-standardised prevalence of IFG, % | - |
| Impaired Glucose Tolerance (IGT) | |
|---|---|
| People with IGT, in 1,000s | - |
| Age-standardised prevalence of IGT, % | - |
| Mortality attributable to diabetes (20-79 y) | |
|---|---|
| Deaths attributable to diabetes | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
|---|---|
| Live births affected by HIP | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - |
| Live births affected by other types of diabetes first detected in pregnancy | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - |
| Diabetes-related health expenditure | |
|---|---|
| Total diabetes-related health expenditure, USD million | - |
| Total diabetes-related health expenditure, ID million | - |
| Diabetes-related health expenditure per person, USD | - |
| Diabetes-related health expenditure per person, ID | - |
| Type 1 diabetes estimates in children and adolescents | |
|---|---|
| People with type 1 diabetes (all age groups) | - |
| People with type 1 diabetes (0-19 y) | - |
| Demographics | |
|---|---|
| Total adult population (20-79 y), in 1,000s | 11,757.0 |
| Population of children and adolescents (0-19 y) | - |
